Related Experiment Video
Updated: May 19, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Vitamin D in children with cystic fibrosis
Malcolm Brodlie1, William A Orchard, Gordon A Reeks
1Paediatric Respiratory Secretaries, Old Children's Outpatients Department, Royal Victoria Infirmary, Newcastle upon Tyne, UK. m.j.brodlie@ncl.ac.uk
Insights
Increased vitamin D supplementation significantly improved 25-hydroxyvitamin D levels in cystic fibrosis children. However, many pancreatic insufficient children still did not reach the recommended target levels.
Area of Science:
- Pediatric Endocrinology
- Nutritional Science
- Cystic Fibrosis Research
Background:
- The Cystic Fibrosis Trust established a 2007 target of 75-150 nmol/L for 25-hydroxyvitamin D (25-OHD).
- A 2008 audit revealed only 10% of pancreatic insufficient (PI) cystic fibrosis children met this target.
Purpose of the Study:
- To assess the impact of increased vitamin D supplementation on 25-OHD levels in PI children.
- To evaluate 25-OHD levels in pancreatic sufficient (PS) children in 2010.
Main Methods:
- PI children (≥1 year) under sole-care received significantly increased Vitamin D3 supplementation (>450%).
- Supplementation regimens included 3800 IU/day liquid or 800 IU daily plus 20,000 IU weekly tablets.
- Pancreatic sufficient (PS) children were audited separately in 2010.
Main Results:
- The median 25-OHD level in PI children rose from 51.5 nmol/L in 2008 to 72 nmol/L in 2010 (p<0.0001).
- The percentage of PI children achieving >75 nmol/L increased from 10% in 2008 to 51% in 2010.
- In 2010, 87% of PS children (n=15) had 25-OHD levels below 75 nmol/L.
Conclusions:
- A substantial increase in vitamin D supplementation significantly improved 25-OHD levels in PI cystic fibrosis children.
- Despite the increase, approximately half of the PI children did not reach the recommended 75 nmol/L target.
- The majority of PS children had insufficient 25-OHD levels, indicating a broader issue.
Purpose:
The Cystic Fibrosis Trust in 2007 published a recommended target of 75-150 nmol/L for 25-hydroxyvitamin D (25-OHD). In 2008 we found that only 10% of pancreatic insufficient (PI) children met this target. An increase in supplementation was implemented and a repeat audit performed in 2010.
Methods:
PI children ≥1 year under sole-care in our regional centre were included. Vitamin D3 supplementation increased by >450% to either 3800 IU/day liquid or 800 IU daily plus 20,000 IU weekly tablets. In 2010 pancreatic sufficient (PS) children were also audited separately.
Results:
The median 25-OHD level increased from 51.5 nmol/L in 2008 (n=78, 10% >75 nmol/L) to 72 nmol/L in 2010 (n=72, 51% >75 nmol/L), p<0.0001. In PS children (n=15 in 2010) 87% had 25-OHD levels <75 nmol/L.
Conclusions:
A substantial increase in supplementation led to a significant increase in 25-OHD levels but around half still failed to reach the recommended target.
More Related Videos
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Vitamins